Local Antibody Feedback Shapes How B Cells Compete During Vaccination


New research reveals how antibodies generated early in an immune response can influence which B cells continue to mature in germinal centres, the sites where high-affinity antibodies are refined (Figure 1).

Figure 1: Graphical abstract.

Using an mRNA-based immunogen displaying three conserved HIV-1 envelope epitopes, researchers tracked B cells engineered to recognize specific targets with defined binding strengths. They found that B cells with higher-affinity receptors did not necessarily dominate the response for long. Instead, these high-affinity cells exited germinal centres more quickly than lower-affinity competitors.

Importantly, competition occurred within individual epitopes. When multiple B cell clones targeted the same epitope, higher-affinity clones suppressed the expansion of lower-affinity counterparts. However, this dominance was tempered by a local feedback mechanism: antibodies produced by nearby plasma cells accumulated in lymph nodes and fed back into germinal centres. This local IgG limited further affinity escalation within a given epitope, effectively setting both lower and upper thresholds for selection.

The study suggests that early, locally produced antibodies regulate germinal centre dynamics by preventing runaway affinity maturation against a single epitope. This self-limiting mechanism may promote broader immune responses by redirecting B cell selection toward alternative epitopes, a process known as epitope spreading.

These findings provide new insight into how antibody feedback shapes vaccine responses and could inform the design of next-generation mRNA vaccines aimed at eliciting broad, durable immunity.

Journal article: Yan, Y., et al. 2026. Local antibody feedback enforces a checkpoint on affinity maturation in the germinal center and promotes epitope spreading. Immunity.

Summary by Stefan Botha

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids Foundation
 

Accessibility Toolbar